• Tue, February 2, 2021

Max Masucci Maintained (BDSX) at Strong Buy with Increased Target to $31 on, Feb 2nd, 2021

Max Masucci of Canaccord Genuity, Maintained "Biodesix, Inc." (BDSX) at Strong Buy with Increased Target from $27 to $31 on, Feb 2nd, 2021.

Max has made no other calls on BDSX in the last 4 months.



There are 2 other peers that have a rating on BDSX. Out of the 2 peers that are also analyzing BDSX, 0 agree with Max's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Max


  • Brian Weinstein of "William Blair" Initiated at Buy on, Monday, November 23rd, 2020
  • Tejas Savant of "Morgan Stanley" Initiated at Buy and Held Target at $20 on, Monday, November 23rd, 2020

Like: 👍